These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6820348)

  • 1. [Mass screening for gastric cancer in the State of Táchira].
    Cano de Mora E; Oliver W; Roa de Buitrago E; Hurtado Z; Ramirez A; Romero F; Lopez V
    G E N; 1981; 35(3-4):137-43. PubMed ID: 6820348
    [No Abstract]   [Full Text] [Related]  

  • 2. [Present status of stomach diseases observed through mass gastric screening].
    Ariga K; Iwasaki M
    Naika; 1966 Jun; 17(6):1004-16. PubMed ID: 5964521
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mass screening of gastric diseases in South Kyoto-Fu].
    Tsuchiya N; Isobe Y
    Iryo; 1972 Mar; 26(3):238-42. PubMed ID: 5027292
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of gastric mass survey.
    Okui K; Tejima H
    Acta Chir Scand; 1980; 146(3):185-7. PubMed ID: 7468039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A pilot study of mass survey for gastric diseases (author's transl)].
    Pan GZ; Chen MC; Dai XZ; Bi ZH; Wen SH; Yao HC; Kang BC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1980 Dec; 2(4):227-31. PubMed ID: 6458372
    [No Abstract]   [Full Text] [Related]  

  • 6. [Importance of prophylactic examinations of high-risk groups for the timely detection of stomach cancer].
    Berzin SA
    Vopr Onkol; 1973; 19(12):87-90. PubMed ID: 4786900
    [No Abstract]   [Full Text] [Related]  

  • 7. [Early gastric cancer: main objective in a mass screening program for gastric cancer].
    Oliver W
    G E N; 1994; 48(3):144-56. PubMed ID: 7768419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment of gastric cancer detected by mass screening.
    Hanazaki K; Sodeyama H; Wakabayashi M; Miyazawa M; Yokoyama S; Sode Y; Kawamura N; Miyazaki T; Ohtsuka M
    Hepatogastroenterology; 1997; 44(16):1126-32. PubMed ID: 9261611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics and progress of treatment for gastric cancers detected by mass screening].
    Muta Y; Baba Y; Nishiyama M; Bandou K; Ogata S; Sakaguti K
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1505-13. PubMed ID: 9725041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case-control study of gastric cancer screening in Venezuela.
    Pisani P; Oliver WE; Parkin DM; Alvarez N; Vivas J
    Br J Cancer; 1994 Jun; 69(6):1102-5. PubMed ID: 8198977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of mass screening for stomach cancer conducted by us in the last ten years (author's transl)].
    Murata Y; Hasegawa M
    Nihon Ika Daigaku Zasshi; 1982; 49(3):433-7. PubMed ID: 7107832
    [No Abstract]   [Full Text] [Related]  

  • 12. Endoscopic screening for gastric cancer.
    Dan YY; So JB; Yeoh KG
    Clin Gastroenterol Hepatol; 2006 Jun; 4(6):709-16. PubMed ID: 16765306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.
    Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Tanaka S; Kajiyama G; Shigenobu T
    Hiroshima J Med Sci; 1997 Jun; 46(2):81-6. PubMed ID: 9232936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of premalignant gastric lesions: implications for the development of screening and surveillance strategies.
    de Vries AC; Kuipers EJ
    Helicobacter; 2007 Nov; 12 Suppl 2():22-31. PubMed ID: 17991173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inflammatory response associated with Helicobacter pylori infection in gastric mucosa with intestinal metaplasia in a population in high risk for gastric cancer].
    Peraza S; Vivas J; López G; Carrillo E; Oliver W; Andrade O; Castro D; Cano E; Sánchez V
    G E N; 1995; 49(1):55-63. PubMed ID: 8566674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of mathematical analysis methods in screening high-risk groups for stomach cancer].
    Kirillova RA
    Vopr Onkol; 1982; 28(2):97-100. PubMed ID: 7064412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric premalignancy and cancer screening in high-risk patients.
    Yoshida S; Saito D
    Am J Gastroenterol; 1996 May; 91(5):839-43. PubMed ID: 8633568
    [No Abstract]   [Full Text] [Related]  

  • 18. [Incidence of atrophic gastritis in high and low-risk areas of gastric cancer].
    Jin ML
    Zhonghua Zhong Liu Za Zhi; 1982 Nov; 4(4):294-7. PubMed ID: 7166110
    [No Abstract]   [Full Text] [Related]  

  • 19. Upper gastrointestinal mass survey with panendoscopy in a workplace.
    Miki K; Hirayama Y; Ichinose M; Niwa H; Oka H; Oda T
    Gastrointest Endosc; 1982 May; 28(2):70-2. PubMed ID: 7084645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extraventricular lesions demonstrated by gastric photofluorographic study.
    Oshiba S; Mochizuki F; Hisamichi S; Sugawara N; Hadori S
    Tohoku J Exp Med; 1976; 118 Suppl():79-84. PubMed ID: 964033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.